Health Care & Life Sciences » Pharmaceuticals | Tianyin Pharmaceutical Co. Inc.

Tianyin Pharmaceutical Co. Inc. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Net Income before Extraordinaries
12,043.20
15,663.00
6,241.90
6,615.20
808.10
Depreciation, Depletion & Amortization
953.80
1,187.80
1,215.20
2,435.10
2,587.60
Other Funds
440.00
-
3,264.80
908.90
3,559.70
Funds from Operations
14,332.90
17,163.50
7,512.60
9,066.30
2,181.50
Changes in Working Capital
1,067.20
2,977.30
437.60
820.20
273.80
Net Operating Cash Flow
15,400.10
14,186.20
7,950.20
8,246.10
2,455.30
Capital Expenditures
8,551.90
12,018.00
5,303.10
15,865.00
13,424.00
Sale of Fixed Assets & Businesses
-
-
545.40
-
-
Net Investing Cash Flow
8,845.20
11,715.70
5,092.30
16,072.30
15,409.00
Cash Dividends Paid - Total
1,409.10
143.00
-
-
-
Issuance/Reduction of Debt, Net
66.00
1,209.00
3,154.40
223.20
1,399.20
Net Financing Cash Flow
7,991.80
1,065.90
134.70
1,132.10
2,160.50
Net Change in Cash
14,656.80
4,715.80
3,427.40
8,325.30
10,707.00
Free Cash Flow
9,590.90
2,168.20
7,394.50
6,732.30
3,995.50
Deferred Taxes & Investment Tax Credit
-
-
-
-
1,180.50
Net Assets from Acquisitions
-
-
-
207.30
-
Other Sources
-
302.20
-
-
-
Change in Capital Stock
8,894.80
-
24.30
-
-
Exchange Rate Effect
110.20
1,179.40
704.30
633.00
86.20
Other Uses
293.30
-
334.60
-
1,984.90

About Tianyin Pharmaceutical Co.

View Profile
Address
23/F, Unionsun Yangkuo Plaza
Chengdu Shanghai 610041
China
Employees -
Website -
Updated 07/08/2019
Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.